Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
Somdatta Saha, Javier González‐Maeso
Neuropharmacology (2023) Vol. 230, pp. 109489-109489
Open Access | Times Cited: 17

Showing 17 citing articles:

Beyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action
Lindsay P. Cameron, Joseph Benetatos, Vern Lewis, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 45, pp. 7472-7482
Open Access | Times Cited: 24
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 23
IUPHAR Review - Novel therapeutic targets for schizophrenia treatment: a translational perspective
Veronica Begni, Alessia Marchesin, Marco Andrea Riva
Pharmacological Research (2025), pp. 107690-107690
Open Access | Times Cited: 1
Psychedelics action and schizophrenia
Marzena Maćkowiak
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1350-1361
Open Access | Times Cited: 11
Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors
Hugo R. Arias, Laura Micheli, Anders A. Jensen, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117887-117887
Open Access
Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs
Keying Liu, Bide Zhang, Zhoufangyuan Chen, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
Neuropharmacology in the Molecular Epoch
Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Bhupendra G. Prajapati
(2025), pp. 31-66
Closed Access
Antipsychotics and dietary interventions: pharmacodynamics, pharmacokinetics and synergisms in therapy
Cristiana Perrotta, Carla Carnovale, Marco Pozzi, et al.
Pharmacological Reviews (2025), pp. 100061-100061
Open Access
Regulatory Molecules of Synaptic Plasticity in Anxiety Disorder
Zhongwei Sha, Jian Xu, Nana Li, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 2877-2886
Open Access | Times Cited: 9
Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters
Samane Jahanabadi, Shayan Amiri, Mehdi Karkeh-abadi, et al.
Fitoterapia (2023) Vol. 169, pp. 105620-105620
Closed Access | Times Cited: 6
BDNF, DRD4, and HTR2A Gene Allele Frequency Distribution and Association with Mental Illnesses in the European Part of Russia
Аnna Morozova, Valeria Ushakova, Olga Pavlova, et al.
Genes (2024) Vol. 15, Iss. 2, pp. 240-240
Open Access | Times Cited: 1
Haloperidol, Olanzapine, and Risperidone Induce Morphological Changes in an In Vitro Model of Human Hippocampal Neurogenesis
Bálint Jezsó, János Kálmán, K Farkas, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 688-688
Open Access | Times Cited: 1
Progress in metamodulation and receptor-receptor interaction: From physiology to pathology and therapy
Anna Pittaluga, Massimo Grilli, Guendalina Olivero
Neuropharmacology (2023) Vol. 237, pp. 109639-109639
Closed Access | Times Cited: 1
Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model
Antonio J. Ortiz, Victor S. Martı́n, David Romero, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116299-116299
Open Access
Translation-independent association of mRNAs encoding protomers of the 5-HT2A-mGlu2 receptor complex in living cells
Somdatta Saha, Javier González‐Maeso
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
CNS Biased Agonism and the Promise of Targeting Drugs Beyond Receptors to Cellular Pathways
Laurence Melnick
(2024), pp. 167-189
Closed Access
Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration
Yimin Yu, Jingjing He, Zhiwei Huang, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 33, Iss. 1, pp. 51-61
Closed Access
Page 1

Scroll to top